Nkarta

$35.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+4.50%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Nkarta and other stocks, options, and ETFs commission-free!

About NKTX

Nkarta, Inc. Common Stock, also called Nkarta, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer.

CEO
Paul J. Hastings
Employees
95
Headquarters
South San Francisco, California
Founded
2005
Market Cap
1.15B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
229.10K
High Today
$35.68
Low Today
$34.02
Open Price
$34.03
Volume
874.93K
52 Week High
$79.16
52 Week Low
$22.46

NKTX Earnings

-$6.08
-$4.05
-$2.03
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 14, Pre-Market

You May Also Like

BABA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure